Refine by
Advanced Sequencing Articles & Analysis
144 news found
Creative Proteomics’ service stands out for its exceptional sensitivity, accuracy, and versatility. Utilizing advanced sequencers, the company can detect amino acids at the picomole level, making it ideal for analyzing challenging samples. ...
Next-generation sequencing (NGS) has revolutionized the field of genomics by enabling researchers to generate vast amounts of sequence data in a single experiment. ...
As the practice worked with SOPHiA GENETICS throughout the year, it experienced the benefits of utilizing the SOPHiA DDM™ Platform for its next generation sequencing (NGS) testing and today announced it will begin to validate the SOPHiA DDM™ RNAtarget Technology and the SOPHiA DDM™ for Comprehensive Genomic Profiling (CGP) application. ...
Alamut™ Visual Plus is an advanced decision-support tool for the exploration, annotation, and interpretation of genetic variants from next-generation sequencing (NGS) data. ...
In this piece, we talked to the two presenters of the poster “The Validation of a Homologous Recombination Deficiency Assay into Clinical Practice within the NHS”, Elizabeth Ratsma, Pre-Registration Clinical Scientist – Cancer Genomics and Charlotte Flanagan, PhD, Innovation Lead, from The Royal Marsden NHS Foundation Trust. The poster was recently presented at the ESMO ...
Together, SOPHiA GENETICS and Boundless Bio pioneered the ecDNA Solution (ECS) algorithm to detect the presence of ecDNA using routine clinical next-generation sequencing (NGS) data. ECS is the first ecDNA clinical trial assay and was designed by SOPHiA GENETICS in alignment with FDA guidelines as an Investigational Use Only Clinical Trial Assay (IUO CTA). ...
CD Genomics, a leading provider of genomic research solutions, today announced the launch of its cutting-edge Nanopore sequencing services, marking a significant advancement in DNA and RNA analysis capabilities. ...
HER2 and FOLR1 testing by immunohistochemistry (IHC) is now available for all solid tumor cancers as an add-on to the company’s xT or xR next-generation sequencing assays. ADCs are an expanding class of therapies designed to target and kill tumor cells while sparing healthy cells. ...
ByTempus
CD Genomics, a leading provider of high-throughput sequencing services, is at the forefront of this exciting development, empowering researchers to unlock the secrets of the lncRNA world through its state-of-the-art LncRNA Sequencing platform. ...
CD Genomics, a leading provider of genomic services, is proud to announce a groundbreaking advancement in microsatellite development that is set to transform the landscape of genetic research. ...
CD Genomics, a leader in genomics and sequencing services, is proud to introduce MeRIP sequencing, a state-of-the-art technology that offers a comprehensive analysis of m6A locations in RNA transcripts. CD Genomics's MeRIP sequencing workflow involves immunoprecipitation of m6A-containing RNA fragments using specific antibodies, followed by ...
CD Genomics, a prominent leader in the next generation sequencing arena, proudly announce the launch of a groundbreaking 5mC/5hmC sequencing service. ...
The critical advancements in CD Genomics' TCR-Seq Technology include unparalleled sensitivity and precision. The upgraded TCR-Seq technology leverages advanced sequencing techniques and cutting-edge bioinformatics analysis, enabling researchers to delve deeper into the nuances of immune responses. ...
CD Genomics, a renowned leader in genomics and next-generation sequencing (NGS) applications, has unveiled its cutting-edge HLA typing solutions, revolutionizing immune profiling and transplantation compatibility assessment. ...
CD Genomics, a global leader in genomic and bioinformatics solutions, is pleased to announce the official launch of its Viral Metagenomic Sequencing service. This state-of-the-art offering represents a major advancement in the field of pathogen research and promises to provide unparalleled insights into viral communities. ...
CD Genomics, a leading provider of genomic solutions, has announced a groundbreaking development in genomic research with the introduction of their Full-Length Transcripts Sequencing (Iso-Seq) technology. This innovative advancement promises to revolutionize the field, providing researchers in the life sciences with an unprecedented opportunity to gain ...
Leveraging their extensive experience and advanced sequencing technologies, CD Genomics offers researchers a comprehensive and efficient solution for DAP-Seq, allowing them to overcome technical hurdles and embark on groundbreaking scientific endeavors. ...
Key Advantages of CD Genomics’ Whole Exome Sequencing Service: Unparalleled Precision and Depth: Employs state-of-the-art next-generation sequencing (NGS) technologies and stringent quality control measures, ensuring highly accurate and reliable sequencing results. Their team of seasoned experts leverages advanced ...
CD Genomics, a global leader in transcriptomics solutions, unveils its mature Nanopore Direct RNA Sequencing service that can propel transcriptomics research to new heights. With this service, CD Genomics empowers researchers to unlock the full potential of their studies with unrivalled precision and efficiency. Harnessing the power of Oxford Nanopore sequencing technology, this revolutionary ...
Key features of CD Genomics' Exosomal RNA Sequencing service include: Enhanced Sensitivity: CD Genomics employs advanced library preparation methods and sequencing platforms, maximizing sensitivity to detect low-abundance transcripts within exosomes. ...